Projects introduction
Kexing Group, which was established in 1989, is the first modernized enterprise focusing on development of bio-pharmaceutical industry in China. Since the beginning of establishment, Kexing Group has devoted itself to " developing new bio-engineering product and strengthening human health ". With more than 20 years of business operation, Kexing Group gradually developed into an biopharmaceutical group integrated with R&D, manufacturing and marketing of bio-pharmaceutical products, Kexing Group has marketed a series of bio-engineering drugs, and one of its products, interferon alpha-1b(brand name is ” Sinogen ") became the number one brand of Interferon in China in 1996, After over 20 years of developments, its products market can cover over 95% hospitals in china Mainland and the sales team consists of over 300 people working in more than 30 sub-branch offices; furthermore, over 100 distributors work together with sales team of Kexing Group in the way of win-win cooperation.
Kexing Group has attached great importance to independent R&D of new products with independent intellectual property and the technological innovation. Meanwhile, Kexing Group paid attention to communication and exchange with various scientific research institutes and universities. Based on the principles of " Honesty, trust, specialty, win- win, complementation and long-term development " , Kexing Group will welcome you to discuss potential collaboration or business developments. If you have any idea relevant to medicine or drug, please feel free to contact us, we will respond as soon as possible.
Project introduction & development method:
A) Technical collaboration:
If you have any technical solution related to process optimization and improvement of special product; or if you want to collaborate in various stages of drug registration (including pre-clinical , post-clinical trial) ; please be free contact us.
B) Business development:
If you have promising drug and want to market in China Mainland, or seek for General agent of China Mainland market, please be free contact us.
Concerned fields:
A) Drugs related to following liver diseases indication: relieving jaundice, relieving hepatic enzymes, anti-hepatic fibrosis, liver protection, anti-HBV/HCV. etc
B) Drugs related to Pediatrics, anti-cancer, dermatosis, hemopathy, venereal disease. etc
C) Medical Device ( including IVD ) with IP
Contact Information：
Mr. Zhang Watterson
Project Development Dept. Manager
TEL：0755-26546155
FAX：0755-26546470
E-mail：zhangsh123@Kexing.com.cn